naphazoline has been researched along with Carcinoma, Squamous Cell in 1 studies
Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.
Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cutaneous squamous cell carcinoma (cSCC) is a frequent side-effect of vemurafenib treatment." | 1.43 | Age and clear eyes are associated with an increased risk of cutaneous squamous cell carcinomas in vemurafenib-treated melanoma patients. ( Aractingi, S; Avril, MF; Boitier, F; Carlotti, A; Chanal, J; Dupin, N; Herms, F; Kramkimel, N; Regnier-Rosencher, E, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herms, F | 1 |
| Kramkimel, N | 1 |
| Regnier-Rosencher, E | 1 |
| Carlotti, A | 1 |
| Chanal, J | 1 |
| Boitier, F | 1 |
| Aractingi, S | 1 |
| Dupin, N | 1 |
| Avril, MF | 1 |
1 other study available for naphazoline and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Age and clear eyes are associated with an increased risk of cutaneous squamous cell carcinomas in vemurafenib-treated melanoma patients.
Topics: Adrenergic alpha-Agonists; Age Factors; Carcinoma, Squamous Cell; Female; Humans; Indoles; Male; Mel | 2016 |